Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations ; volume:7 ; number:1 ; day:23 ; month:12 ; year:2019 ; pages:1-17 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (23.12.2019), 1-17, 12.2019

Creator: Arrant, Andrew E.
Roth, Jonathan R.
Boyle, Nicholas R.
Kashyap, Shreya N.
Hoffmann, Madelyn Q.
Murchison, Charles F.
Ramos, Eliana Marisa
Nana, Alissa L.
Spina, Salvatore
Grinberg, Lea T.
Miller, Bruce L.
Seeley, William W.
Roberson, Erik D.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-019-0872-6

URN: urn:nbn:de:101:1-2020032713485046701940

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Arrant, Andrew E.
Roth, Jonathan R.
Boyle, Nicholas R.
Kashyap, Shreya N.
Hoffmann, Madelyn Q.
Murchison, Charles F.
Ramos, Eliana Marisa
Nana, Alissa L.
Spina, Salvatore
Grinberg, Lea T.
Miller, Bruce L.
Seeley, William W.
Roberson, Erik D.
SpringerLink (Online service)

Other Objects (12)

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations

Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia

Progranulin in frontotemporal lobar degeneration and neuroinflammation

Neuropathological and behavioral characterization of aged Grn R493X progranulin-deficient frontotemporal dementia knockin mice

Single-cell multimodal analysis in a case with reduced penetrance of Progranulin-Frontotemporal Dementia

Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Impaired self-other differentiation in frontotemporal dementia due to the C9ORF72 expansion

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations

Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia

Related objects

Reset password